UV SUPPORT- benzophenon-3, ethylhxyl salicyclate, homosalate, octocrylene, butyl methoxydibenzoyl methae, titanium dioxide, hydroxystearyl alcohol cream 
Novamed Healthcare Private Limited

----------

UV Support

Instructions for Use

For best results and full protection apply UV-support to all exposed skin 15 minutes before sun exposure. Reapply UV-support after every two hours or as per need.

Indications and Usage

  • Protects against harmful UVA/UVB rays
  • Protects from sun burn
  • Reduces premature aging and wrinkling
  • Prevents dry & rough skin
  • Fills uneven skin surface
  • Water and sweat resistant

Inactive Ingredients

  • Acrylamide/Sodium Acryloyldimethyltaurate Copolymer
  • Caprylic/Capric Triglyceride
  • Caprylyl/Capryl Glucoside
  • Cetostearyl alcohol
  • Cetyl alcohol
  • Cyclomethicone
  • EDTA
  • Ethylene glycol distearate
  • Glycerin
  • Sodium benzoate
  • Sodium lauryl sulphate
  • Stearic acid
  • Triethanolamine
  • Water

Active Ingredients

  • Benzophenon
  • Butyl methoxydibenzoyl methane
  • Ethylhexyl salicylate
  • Homosalate
  • Hydroxystearyl Alcohol
  • Octocrylene
  • Titanium dioxide

Keep out of the reach of Children

Keep out of the reach of Children

Purpose

Active Ingredient Purpose

Benzophenon Sunscreen (UV-A +UV-B protection)
Butyl methoxydibenzoyl methane Sunscreen (UV-A protection)
Ethylhexyl salicylate Sunscreen (UV-B protection)
Homosalate Sunscreen (UV-B protection)
Hydroxystearyl Alcohol Emulsifier
Octocrylene Sunscreen (UV-A +UV-B protection)
Titanium dioxide Opacifier + Sunscreen (UV-B protection)

Warnings

  • In case of allergic reaction stop the use immediately & consult your doctor.
  • Avoid contact with eyes.
  • For external use only.
  • Keep out of the reach of children

Dosage and Administration

UV-support should be used year-round before going outside.

Apply UV-support to all exposed skin 15 minutes before sun exposure.

Reapply UV-support after every two hours or as per need.

UV Support

UV Support

UV SUPPORT 
benzophenon-3, ethylhxyl salicyclate, homosalate, octocrylene, butyl methoxydibenzoyl methae, titanium dioxide, hydroxystearyl alcohol cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84859-115
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BUTYL METHOXYDIBENZOYLMETHANE (UNII: G63QQF2NOX) (BUTYL METHOXYDIBENZOYLMETHANE - UNII:G63QQF2NOX) BUTYL METHOXYDIBENZOYLMETHANE0.9 g  in 30 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.75 g  in 30 g
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE1.2 g  in 30 g
HYDROXYSTEARYL ALCOHOL (UNII: UN9IN5VLYE) (HYDROXYSTEARYL ALCOHOL - UNII:UN9IN5VLYE) HYDROXYSTEARYL ALCOHOL0.6 g  in 30 g
BENZOPHENONE (UNII: 701M4TTV9O) (BENZOPHENONE - UNII:701M4TTV9O) BENZOPHENONE1.2 g  in 30 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE3 g  in 30 g
ETHYLHEXYL SALICYLATE (UNII: 4X49Y0596W) (ETHYLHEXYL SALICYLATE - UNII:4X49Y0596W) ETHYLHEXYL SALICYLATE1.5 g  in 30 g
Inactive Ingredients
Ingredient NameStrength
ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%) (UNII: 5F4963KLHS) 0.3 g  in 30 g
TRIETHANOLAMINE (UNII: 9O3K93S3TK) 0.18 g  in 30 g
SODIUM BENZOATE (UNII: OJ245FE5EU) 0.09 g  in 30 g
GLYCERIN (UNII: PDC6A3C0OX) 0.9 g  in 30 g
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U) 0.75 g  in 30 g
CETYL ALCOHOL (UNII: 936JST6JCN) 0.9 g  in 30 g
CYCLOMETHICONE (UNII: NMQ347994Z) 0.9 g  in 30 g
STEARIC ACID (UNII: 4ELV7Z65AP) 2.4 g  in 30 g
EDTA (UNII: 9G34HU7RV0) 0.03 g  in 30 g
CAPRYLYL/CAPRYL GLUCOSIDE (UNII: E00JL9G9K0) 0.15 g  in 30 g
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) 0.9 g  in 30 g
WATER (UNII: 059QF0KO0R) 11.667 mL  in 30 g
SODIUM LAURYL SULFATE (UNII: 368GB5141J) 0.15 g  in 30 g
DIETHYLENE GLYCOL DISTEARATE (UNII: 617Q4OD69O) 0.9 g  in 30 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:84859-115-011 in 1 BOX02/26/202504/24/2025
1NDC:84859-115-3030 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02002/26/202504/24/2025
Labeler - Novamed Healthcare Private Limited (645814547)
Registrant - Novamed Healthcare Private Limited (645814547)
Establishment
NameAddressID/FEIBusiness Operations
Novamed Healthcare Private Limited645814547manufacture(84859-115) , label(84859-115) , pack(84859-115)

Revised: 5/2025
 
Novamed Healthcare Private Limited